We have experience in wide range of disease areas, many of which are not current conflicts. The following is not an exhaustive list! Please click on the titles for further information.
- Allergy
- An on-going media relations support programme for an oral grass pollen vaccine, Grazax
- Support for Epi-pen, an adrenaline auto-injector for severe allergic reactions
- Anaesthesia
- Pre-launch and launch programme for Glaxo Wellcome's Ultiva and Nimbex
- Support for Ultiva, Elan's intravenous analgesic agent for intra-operative use and in the ICU
- Awareness Campaign for the Pain Society
- Support for Epi-pen, an adrenaline auto-injector for severe allergic reactions
- Anti-infectives
- Support for Chiron's inhaled antibiotic TOBI - UK and European programme
- Production of consensus report on management of MRSA in cystic fibrosis
- Launch of Doribax for Janssen-Cilag, a new, broad-spectrum, intravenous carbapenem antibiotic for difficult-to-treat pathogens
- Programme of support for Acticoat on behalf of Smith & Nephew, a silver-lined wound dressing effective against MRSA
- Cardiovascular
- UK communications programme for Tracleer® (bosentan) in the orphan disease area of pulmonary arterial hypertension on behalf of Actelion Pharmaceuticals. A wide ranging programme of activities includes patient education, congress symposium development and implementation, media relations for medical and consumer journalists, KOL development and internal communications
- Dermatology
- UK communications programme for Remicade® (infliximab) in severe psoriasis and psoratic arthritis on behalf of Schering-Plough
- Market entry and trade and consumer activities for Merck Sharp & Dohme to support Propecia®, an oral treatment for male pattern baldness
- Support for Glaxo Dermatology's established topical steroid portfolio and prelaunch/launch programme for Cutivate
- Press office function and annual awareness week for the National Eczema Society
- Support for Protopic, a topical immunomodulator for the treatment of moderate to severe eczema
- Communications support for the 'Diploma in Practical Dermatology', a distance learning one year course for family doctors/GPs around the world
- Corporate / internal
- Internal communications and development of a quarterly company newsletter for Altana
- Internal communications for the launch of Cymbalta for Lilly
- UK corporate roadshow for the Royal Pharmaceutical Society
- Internal communications programme for Actelion UK including e-newsletter and team building activities
- Female Health
- Media launch and on-going communications progamme for Prolia, a novel biologic treatment for osteoporosis
- On-going communications to support Vaniqa for female hirsutism and consumer awareness programme, We Can Face It
- Gastroenterology
- Broad ranging UK communications for Remicade®(infliximab) in the area of inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease on behalf of Schering-Plough
- Male Health
- On-going communications support for Avodart, GSK’s 5ARI for the treatment of Benign Prostatic Hyperplasia (BPH) and launch of new product for prostate health
- Pre-launch, launch and post-launch communications programme to support Propecia® (finasteride) including patient education and professional relations activity in the area of male pattern hair loss (MPHL)
- Mental Health
- Medical education programme for Aricept® (donepezil hydrochloride), Eisai and Pfizer's cholinesterase inhibitor for Alzheimer's disease and dementia. Work includes the creation and implementation of tailored training programmes for SpRs in Old Age Psychiatry and specialist dementia nurses
- UK pre-launch and launch activity to support Cymbalta, an SNRI antidepressant marketed by Lilly and Boehringer Ingelheim. Programme of activities included GP survey development, creation of educational guides and training workshops for journalists as well as full press office support
- Neurology
- Pre-launch and launch programme for Elan Pharma's Zanaflex for spasticity
- Launch of Elan Pharma's Zelapar for Parkinson's Disease
- Production of field force training manual for Ipsen's Dysport
- Launch of Elan Pharma's NeuroBloc for cervical dystonia
- Press office for the MS Trust
- Launch of AstraZeneca's Zomig Rapimelt
- Trade launch of Pfizer's Relpax, an oral treatment for migraine
- Media activity to support Pain Awareness Week for the Pain Society
- Launch of Ionsys, a post-operative pain relieving device
- Oncology
- On-going communications support for GSK’s oncology portfolio: Tyverb, Votrient, Arzerra, Atriance, Hycamtin and Revolade
- Public awareness campaigns to support Kidney Cancer UK including running Kidney Cancer Awareness Week and full press office support
- Communications support for Prostap, Wyeth’s LHRH for prostate cancer
- Respiratory medicine
- Support for 3M Health Care's respiratory portfolio including Qvar, Aeromir and AeroChamber
- Writing and production of British Lung Foundation's newsletter, Breathe Easy
- Management of the National Respiratory Training Centre (NRTC) press office
- Rheumatology
- UK communications programme for Remicade® (infliximab) in the area of rheumatic diseases such as rheumatoid arthritis and ankylosing spondylitis on behalf of Schering-Plough
- Thrombosis
- A consumer and professional awareness and mobilisation campaign to prevent unnecessary deaths from hospital acquired blood clots
- A medical education project: on-line CPD programme incorporating innovative avatar technology
